Ozempic, Insulin Resistance, and Type 2 Diabetes: What Are We Missing? | Dr. Mariela Glandt | The Metabolic Link Ep. 98
About this episode
Dr. Mariela Glandt discusses the need to rethink the treatment of type 2 diabetes by focusing on insulin resistance.
Attend a Live Q&A with Dr. Glandt. Reigster here. What if the way we treat type 2 diabetes is fundamentally backwards? Dr. Mariela Glandt is an endocrinologist and obesity medicine specialist who spent 15 years practicing conventional medicine before concluding, in her words, that how we treat diabetes “is actually upside down.” As co-founder of OwnaHealth, she focuses on addressing the insulin resistance underlying type 2 diabetes, not only the elevated blood sugar it eventually causes. ...
People in this episode
Hosts: Dr. Dominic D'Agostino, Dr. Angela Poff, Victoria Field
Guest: Dr. Mariela Glandt
Mentioned in this episode
Organizations: OwnaHealth
More episodes of The Metabolic Link
- Type 1 Diabetes on a Ketogenic Diet: What a 1,000-Mile Bike Ride Revealed | Dr. Ian Lake | The Metabolic Link Ep. 99
- Treating PTSD When Standard Care Falls Short: A Hyperbaric Oxygen Protocol | Dr. Keren Doenyas-Barak, MD | The Metabolic Link Ep. 97
Explore listener stats, chart rankings, contacts and more on the The Metabolic Link podcast page.